Acute myocardial infarction and Flushing aggravated

Summary:

Flushing aggravated is found among people with Acute myocardial infarction, especially for people who are male, 60+ old.

The study analyzes which people have Flushing aggravated with Acute myocardial infarction. It is created by eHealthMe based on reports of 14 people who have Acute myocardial infarction from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Acute myocardial infarction?

Acute myocardial infarction (acute heart attack) is found to be associated with 1,452 drugs and 1,622 conditions by eHealthMe. Check the latest studies of Acute myocardial infarction.

What is Flushing aggravated?

Flushing aggravated (the warm, red condition of human skin) is found to be associated with 1,455 drugs and 459 conditions by eHealthMe. Check the latest studies of Flushing aggravated.



On Aug, 04, 2026

14 people who have Acute Myocardial Infarction and Flushing Aggravated are studied.

Would you have Flushing aggravated when you have Acute myocardial infarction?

Gender of people who have Acute Myocardial Infarction and experienced Flushing Aggravated *:

  • female: 25 %
  • male: 75 %

Age of people who have Acute Myocardial Infarction and experienced Flushing Aggravated *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 28.57 %
  • 50-59: 28.57 %
  • 60+: 42.86 %

Common co-existing conditions for these people *:

  1. Stress Cardiomyopathy (stress-induced chronic disease of the heart muscle): 1 person, 7.14%
  2. Stable Angina (a constant chest pain): 1 person, 7.14%
  3. Pneumonia: 1 person, 7.14%
  4. Phaeochromocytoma (vascular tumour of the adrenal gland): 1 person, 7.14%
  5. Kounis Syndrome (the concurrence of heart pain with conditions associated with mast cell activation leads to heart muscle damage): 1 person, 7.14%
  6. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 7.14%
  7. Essential Hypertension (primary hypertension): 1 person, 7.14%
  8. Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 1 person, 7.14%

Common drugs taken by these people *:

  1. Activase: 5 people, 35.71%
  2. Brilinta: 4 people, 28.57%
  3. Reopro: 2 people, 14.29%
  4. Ondansetron: 2 people, 14.29%
  5. Nitroglycerin: 2 people, 14.29%
  6. Demerol: 2 people, 14.29%
  7. Hexabrix: 2 people, 14.29%
  8. Zantac: 1 person, 7.14%
  9. Epinephrine: 1 person, 7.14%
  10. Aspirin: 1 person, 7.14%

Common symptoms for these people *:

  1. Chest Pain: 5 people, 35.71%
  2. Rashes (redness): 3 people, 21.43%
  3. Nausea And Vomiting: 3 people, 21.43%
  4. Nausea (feeling of having an urge to vomit): 3 people, 21.43%
  5. Hyperhidrosis (abnormally increased sweating): 3 people, 21.43%
  6. Ventricular Extrasystoles (premature cardiac contraction): 2 people, 14.29%
  7. Bleeding Into The Skin: 2 people, 14.29%
  8. Stress And Anxiety: 2 people, 14.29%
  9. Moaning (a low, sustained, mournful cry): 2 people, 14.29%
  10. Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Flushing aggravated?

- Check whether Flushing aggravated is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Flushing aggravated:

All the conditions that are associated with Flushing aggravated:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Flushing aggravated and Acute myocardial infarction, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: